The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 23, 2003, Pages 4193-4196

  Thomasco, Lisa M ^a   Gadwood, Robert C ^a   Weaver, Elizabeth A ^a   Ochoada, Jason M ^a   Ford, Charles W ^a   Zurenko, Gary E ^a   Hamel, Judith C ^a   Stapert, Douglas ^a   Moerman, Judy K ^a   Schaadt, Ronda D ^a   Yagi, Betty H ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,4 THIADIAZOLE DERIVATIVE; 4 [5 [(ACETYLAMINO)METHYL] 2 OXO 3 OXAZOLIDINYL] 2 FLUOROBENZENECARBOTHIOIC ACID HYDRAZIDE; ACETAMIDE; ANTIINFECTIVE AGENT; HYDRAZIDE DERIVATIVE; LINEZOLID; MORPHOLINE; OXAZOLIDINONE DERIVATIVE; PHENYL GROUP; THIOACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MOUSE; NONHUMAN; RAT; STAPHYLOCOCCUS AUREUS;

NEGIBACTERIA; POSIBACTERIA;

EID: 10744232696     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.07.018     Document Type: Article

References (16)

1. Rybak M.J. J. Hosp. Infect. 49:2001;S25.
2. Linden P.K. Drugs. 62:2002;425.
3. Khurshid M.A., Chou T., Carey R., Larsen R., Conover C., Bornstein S.L. MMWR Morb. Mortal. Wkly. Rep. 48:2000;1165.
4. Thornsberry C., Sahm D.F., Kelly L.J., Critchley I.A., Jones M.E., Evangelista A.T., Kalrowsky J.A. Clin. Infect. Dis. 34:2002;S4.
5. Brickner S.J. Curr. Pharm. Des. 2:1996;175.
6. Park C.H., Brittelli C.L., Wang J., Marsh F.D., Gregory W.A., Wuonola M.A., McRipley R.J., Eberly V.S., Slee A.M., Forbes M. J. Med. Chem. 1992;1156.
7. Carlson, R. K.; Park, C.-H.; Gregory, W. A. US Patent 5,130,316, 1992. CAN 113:172003.
8. Lee C.S., Allwine D.A., Barbachyn M.R., Grega K.C., Dolak L.A., Ford C.W., Jensen R.J., Seest E.P., Hamel J.C., Schaadt R.D., Stapert D., Yagi B.H., Zurenko G.E., Genin M.J. Bioorg. Med. Chem. 9:2001;3243.
9. Hutchinson, D. K. US Patent 5,910,504, 1999. CAN 131:18998.
10. Kohrt A., Hartke K. Liebigs Ann. Chem. 1992;595.
11. Stillings M.R., Welbourne A.P., Walter D.S. J. Med. Chem. 29:1986;2280.
12. Tokuyama R., Takahashi Y., Tomita Y., Suzuki T., Yoshida T., Iwasaki N., Kado N., Okezaki E., Nagata O. Chem. Pharm. Bull. 49:2001;347.
13. Hester, J. B. US Patent 6,362,189, 2000.
14. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, 6th ed.; Approved Standard; NCCLS Document M7-A6; NCCLS; 940 West Valley Road, Suite 1400, Wayne, PA, 2003; 19087 (broth micro dilution method).
15. Ford C.W., Hamel J.C., Wilson D.M. Antimicrob. Agents Chemother. 40:1996;1508.
16. Gadwood, R. C.; Thomasco, L. M.; Anderson, D. J. US Patent 5,977,373, 1999.